Histopathological study of delayed regraft after corneal graft failure

Cornea

Volumn 30, Issue 2, 2011, Pages 167-170

  Santos, Leonardo N ^a,b   De Moura, Leticia Rielo ^a,b   Fernandes, Bruno F ^a,b   Cheema, Devinder P ^a   Burnier Jr , Miguel N ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

corneal; failure; graft; histopathology

Indexed keywords

AGED; ARTICLE; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; FEMALE; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KERATOPLASTY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CORNEAL STROMA; CORNEAL TRANSPLANTATION; FEMALE; GRAFT REJECTION; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 78651354279     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181e843e5     Document Type: Article

References (41)

1. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-1402.
2. Sit M, Weisbrod DJ, Naor J, et al. Corneal graft outcome study. Cornea. 2001;20:129-133.
3. Niederkorn JY. The immune privilege of corneal allografts. Transplantation. 1999;67:1503-1508.
4. Yamada J. New insights into prevention of donor-specific corneal graft rejection. Cornea. 2000;19(Suppl 3):177-182.
5. Waldock A, Cook SD. Corneal transplantation: How successful are we? Br J Ophthalmol. 2000;84:813-815.
6. Randleman JB, Stulting RD. Prevention and treatment of corneal graft rejection: Current practice patterns (2004). Cornea. 2006;25:286-290.
7. Beauregard C, Huq SO, Barabino S, et al. Keratocyte apoptosis and failure of corneal allografts. Transplantation. 2006;81:1577-1582.
8. Price MO, Thompson RW Jr, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol. 2003;121: 1087-1092.
9. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea. 2000; 19:813-816.
10. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1996-2000. Cornea. 2002;21: 148-151.
11. Maeno A, Naor J, Lee HM, et al. Three decades of corneal transplantation: Indications and patient characteristics. Cornea. 2000;19:7-11.
12. Kang PC, Klintworth GK, Kim T, et al. Trends in the indications for penetrating keratoplasty, 1980-2001. Cornea. 2005;24:801-803.
13. Weisbrod DJ, Sit M, Naor J, et al. Outcomes of repeat penetrating keratoplasty and risk factors for graft failure. Cornea. 2003;22:429-434.
14. Vanathi M, Sharma N, Sinha R, et al. Indications and outcome of repeat penetrating keratoplasty in India. BMC Ophthalmol. 2005;5:26.
15. Dandona L, Ragu K, Janarthanan M, et al. Indications for penetrating keratoplasty in India. Indian J Ophthalmol. 1997;45:163-168.
16. Sony P, Sharma N, Sen S, et al. Indications of penetrating keratoplasty in northern India. Cornea. 2005;24:989-991. (Pubitemid 41688537)
17. Bersudsky V, Blum-Hareuveni T, Rehany U, et al. The profile of repeated corneal transplantation. Ophthalmology. 2001;108:461-469.
18. Claerhout I, Beele H, De Bacquer D, et al. Factors influencing the decline in endothelial cell density after corneal allograft rejection. Invest Ophthalmol Vis Sci. 2003;44:4747-4752.
19. Bourne WM. Cellular changes in transplanted human corneas. Cornea. 2001;20:560-569.
20. Bertelmann E, Pleyer U, Rieck P. Risk factors for endothelial cell loss post-keratoplasty. Acta Ophthalmol Scand. 2006;84:766-770.
21. Bell KD, Campbell RJ, Bourne WM. Pathology of late endothelial failure: Late endothelial failure of penetrating keratoplasty: Study with light and electron microscopy. Cornea. 2000;19:40-46.
22. Nishimura JK, Hodge DO, Bourne WM. Initial endothelial cell density and chronic endothelial cell loss rate in corneal transplants with late endothelial failure. Ophthalmology. 1999;106:1962-1965.
23. Bertelmann E, Hartmann C, Scherer M, et al. Outcome of rotational keratoplasty: Comparison of endothelial cell loss in autografts vs allografts. Arch Ophthalmol. 2004;122:1437-1440.
24. Birnbaum F, Reinhard T, Ulbricht T, et al. [Functional results after autologous rotational keratoplasty. A retrospective study]. Ophthalmologe. 2004;101:54-58.
25. Price FW Jr, Price MO. Endothelial keratoplasty to restore clarity to a failed penetrating graft. Cornea. 2006;25:895-899.
26. Inoue K, Amano S, Oshika T, et al. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand. 2001; 79:251-255. (Pubitemid 32577308)
27. Dua HS, Azuara-Blanco A. Corneal allograft rejection: Risk factors, diagnosis, prevention, and treatment. Indian J Ophthalmol. 1999;47:3-9.
28. Dandona L, Naduvilath TJ, Janarthanan M, et al. Survival analysis and visual outcome in a large series of corneal transplants in India. Br J Ophthalmol. 1997;81:726-731.
29. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45: 2666-2673.
30. Uchino Y, Goto E, Takano Y, et al. Long-standing bullous keratopathy is associated with peripheral conjunctivalization and limbal deficiency. Ophthalmology. 2006;113:1098-1101.
31. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology. 1994;101:1536-1547.
32. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050.
33. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115:2363-2372.
34. Sugar A. Should we be paying more attention to corneal neovascularization? Am J Ophthalmol. 2006;141:358-359.
35. Lam VM, Nguyen NX, Martus P, et al. Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol. 2006;141:260-266.
36. Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci. 2000;41:2148-2153.
37. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci. 1996;37: 2485-2494.
38. Cursiefen C, Chen L, Dana MR, et al. Corneal lymphangiogenesis: Evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003;22:273-281.
39. Kobayashi N, Kabuyama Y, Sasaki S, et al. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002;21:62-67.
40. Fossarello M, Peiretti E, Zucca I, et al. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea. 2003;22:485-488.
41. Cursiefen C, Wenkel H, Martus P, et al. Impact of short-term versus longterm topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2001;239:514-521.